XE250 pCDNA3.1 + (zeo)- VSV-KLHL12-Q405X
(Plasmid
#16759)
-
Depositing Lab
-
Publication
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 16759 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepCDNA3.1+zeo
-
Backbone manufacturerInvitrogen
- Backbone size w/o insert (bp) 5015
-
Vector typeMammalian Expression
-
Selectable markersZeocin
Growth in Bacteria
-
Bacterial Resistance(s)Bleocin (Zeocin), 50 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameVSV-KLHL12-Q405X
-
Alt nameKLHL12
-
Alt namekelch-like 12
-
SpeciesH. sapiens (human)
-
Insert Size (bp)1771
-
MutationQ405STOP
-
Entrez GeneKLHL12 (a.k.a. C3IP1, DKIR)
-
Tag
/ Fusion Protein
- vsv
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site BamH1 (not destroyed)
- 3′ cloning site Not1 (not destroyed)
- 5′ sequencing primer T7
- 3′ sequencing primer BGH_rev (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
pCDNA3.1 + (zeo)- VSV-KLHL12-Q405X.
Nature Cell Biology 8, 348 - 357 (2006)
Addgene Qc found an M11L point mutation that does not affect function.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
XE250 pCDNA3.1 + (zeo)- VSV-KLHL12-Q405X was a gift from Randall Moon (Addgene plasmid # 16759 ; http://n2t.net/addgene:16759 ; RRID:Addgene_16759) -
For your References section:
The KLHL12-Cullin-3 ubiquitin ligase negatively regulates the Wnt-beta-catenin pathway by targeting Dishevelled for degradation. Angers S, Thorpe CJ, Biechele TL, Goldenberg SJ, Zheng N, MacCoss MJ, Moon RT. Nat Cell Biol. 2006 Apr . 8(4):348-57. 10.1038/ncb1381 PubMed 16547521